Did anybody catch the first ever YouTube democratic debate last week? It was cosponsored by CNN and the cool thing about it was this: all the questions came in from Americans like you and me. Turns out two of the candidates spoke out on behalf of diabetes. Here's what they had to say...

Governor Richardson mentioned the fact that 33% of Medicare is wrapped up in diabetes costs. He suggests, "Let's have major prevention programs, and also ways that we can ensure that we find a cure." He still has not announced a plan to ensure a cure. But if he does - I'm willing to bet all of his campaign funding from Big Pharma might mysteriously disappear.

The other candidate addressing diabetes was Senator Chris Dodd of Connecticut. Dodd's promise came after from a woman's question about stem cell research. Somehow the senator was able to plug an endeavor to "deal with diabetes". However, much like Governor Richardson - he has yet to announce a plan to cure. Politics as usual. Stay tuned for the LIVE Republican Debate on September 17th.

House Calls, a popular newsletter written by the prestigious Dr. Inglis, highlights a very important question in light of the Avandia mishap: how many other potential whistle-blowers are out there who have been silenced into submission before the Big Pharma vultures?

A medical expert testified that he agreed to sign a statement that was meant to appease the company's investors. This is not the type of behavior anyone should expect or dismiss of a doctor, entrusted with a patient's life. In his defense, he did forward a letter with his concerns to the FDA, which means they also were aware of the same threat. This same doctor is the President-elect for none other than the American Diabetes Association. Isn't that special? The ADA -- my friend, my confidant, my utter supporter of the C-peptide crusade ... sense the sarcasm? So much for advocacy, when the president-elect of this organization so willingly swept those safety concerns under the table, when he should have been throwing a tantrum on top of it! And all over the threat of litigation from a drug company more concerned about its investors than patients.

The closing comments in Dr. Inglis' newsletter say it all: There are so many vultures out there waiting to pick the bones of the American public, it disgusts me. This example goes to show why I always recommend to you -- and to all of my patients -- that you always question everything when it comes to your health. I don't care if it's your doctor you've had for 50 years or one of these nonprofit organizations -- give them all hell.

Diabetes is making a name for itself and it's spreading like wildfire. Politicians are uniting to build a $120 million campaign to educate diabetics to prevent the spread of the disease and its complications.

Senator Clinton criticizes the reaction to the problem, rather than taking measures to prevent it from occurring. She questions why current money is unquestionably $pent on treating complications from diabetes -- such as amputations and dialysis. Good point, Senator. Ask Bush if he's got any friends up at Eli Lilly. A good answer can always be found in a temporary restraining order. She and fellow politicians propose more money be spent on programs for weight-loss, nutrition education and other preventive efforts to best curtail the growing number of diabetics in the United States.

The legislation proposed would provide $90 million to the Centers for Disease Control and Prevention's Division of Diabetes Translation for diabetes surveillance, research and educational activities. It would also allot $30 million for three four-year projects that would examine how best to translate diet and exercise interventions into effective clinical practice.

On March 13, 2007, former President Bill Clinton joined global leaders to discuss ways to break the curve of the diabetes pandemic. The Global Changing Diabetes Leadership Forum held in New York City was hosted by Novo Nordisk and supported by the International Diabetes Federation (IDF). Yes, when people of this magnitude get together - you know it's serious business!

The forum convened the Masters of the Healthcare Universe to discuss ways to make diabetes a global health priority and ultimately, improve the way the disease is treated. The attendees were policymakers, patient organizations and healthcare professionals. It is estimated that 1 in 3 American children born in 2000 and beyond will develop type 2 diabetes. Worldwide, an estimated 246 million people have diabetes, and the number is expected to grow to 380 million within the next 20 years. A resolution today could prevent this harrowing disaster of tomorrow.

The Global Changing Diabetes Leadership Forum hopes to redefine healthcare around the needs of people with diabetes. Novo Nordisk has recognized that there is not a single answer to the diabetes pandemic. They seek to identify multiple actions to combat diabetes - from prevention to the treatment of serious complications. Lars Rebien Sørensen, president and CEO of Novo Nordisk says, . "Only by placing the person with diabetes at the center of care and changing how healthcare systems around the world approach the disease can this silent killer be defeated."

Novo Nordisk anticipates hosting a 2-day forum with this goal in mind. The forum will entail influential figures from around the world, participating in a series of workshops and dialogues designed to evoke a provocative debate about how to chart a course for changing diabetes management globally. For further details on the UN Resolution, please visit the unite for diabetes site.